Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a38a062781e4e44718aa12bb10a153b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 |
filingDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5ba337cb446cc7ba9acb90414075ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e3e5dc864331ad85082b683c795d828 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edc0b0c35984e82ab86da9c811af5905 |
publicationDate |
2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-108822149-A |
titleOfInvention |
A kind of preparation method of key intermediate of tenofovir alafenamide fumarate |
abstract |
The present invention belongs to the field of medicine synthesis, and relates to a preparation method of a medicine intermediate, in particular to a preparation method of a key intermediate of tenofovir alafenamide fumarate. The present invention provides a new method for preparing tenofovir alafenamide fumarate key intermediate 2 with high diastereomer purity. The method has the advantages of short reaction time, few by-products, simple operation and high product quality Good quality, high reaction yield, more suitable for industrial production and other characteristics. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111484527-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111484528-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115651023-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110272455-A |
priorityDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |